RecruitingNCT05754645

The Microbiome in (Non-) Obese Pregnancy and Pregnancy Outcomes

The PROMOTE Study, a Pilot: The Characterization of the Microbiome in Pregnancy and Prediction of Pregnancy Outcomes

Sponsor

Erasmus Medical Center

Enrollment

110 participants

Start Date

Jul 21, 2022

Study Type

OBSERVATIONAL

Conditions

Pregnancy Complications Gut Microbiota Obesity, Maternal

Summary

This research aims to elucidate an underlying mechanism of maternal obesity induced pregnancy and longterm health complications for mothers and their offspring.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria5

Participation in Predict study
Preconceptional women who wish to become pregnant or pregnancy <13 weeks of gestational age.
BMI > 30 kg/m2 or 18-25 kg/m2
Understanding of Dutch in speaking and reading
Willingness to give written informed consent

Exclusion Criteria7

Age < 18 years and > 45 years.
≥13 weeks of gestational age
Multiple pregnancy
Smoking
Gastro-intestinal diseases, heart diseases, liver, pancreas and kidney diseases.
Use of antibiotics < 2 weeks before sampling
Pre-existent diabetes mellitus

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERBlood withdrawal

venous punction with blood withdrawal Vaginal and rectal swab, done by patient itself

Locations(1)

Erasmus MC

Rotterdam, South Holland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05754645

Related Trials

MiCrobiota-gut-brain Axis in Resistant Epilepsy

NCT070104451 location

Glycemic Markers for Predicting Gestational Diabetes in Pregnant Women With Previous Bariatric Surgery

NCT075174061 location